Arkolith/Insider Trading/COLL/Form 4

Freund John Gordon

DirectorCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Jun 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$202K
Net Open-Market Flow
-$202K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2025Option exercise(M)15K$13.45$202K77K
Jun 9, 2025Sell(S)7K$30.62$202K71K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 9, 2025Option exercise(M)15K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-011425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML